Literature DB >> 35435932

Prevalence of Children With Medical Complexity and Associations With Health Care Utilization and In-Hospital Mortality.

JoAnna K Leyenaar1,2, Andrew P Schaefer2, Seneca D Freyleue2, Andrea M Austin2, Tamara D Simon3,4, Jeanne Van Cleave5, Erika L Moen2,6, A James O'Malley2,6, David C Goodman1,2.   

Abstract

Importance: Children with medical complexity (CMC) have substantial health care needs and frequently experience poor health care quality. Understanding the population prevalence and associated health care needs can inform clinical and public health initiatives. Objective: To estimate the prevalence of CMC using open-source pediatric algorithms, evaluate performance of these algorithms in predicting health care utilization and in-hospital mortality, and identify associations between medical complexity as defined by these algorithms and clinical outcomes. Design, Setting, and Participants: This retrospective cohort study used all-payer claims data from Colorado, Massachusetts, and New Hampshire from 2012 through 2017. Children and adolescents younger than 18 years residing in these states were included if they had 12 months or longer of enrollment in a participating health care plan. Analyses were conducted from March 12, 2021, to January 7, 2022. Exposures: The pediatric Complex Chronic Condition Classification System, Pediatric Medical Complexity Algorithm, and Children With Disabilities Algorithm were applied to 3 years of data to identify children with complex and disabling conditions, first in their original form and then using more conservative criteria that required multiple health care claims or involvement of 3 or more body systems. Main Outcomes and Measures: Primary outcomes, examined over 2 years, included in-hospital mortality and a composite measure of health care services, including specialized therapies, specialized medical equipment, and inpatient care. Outcomes were modeled using logistic regression. Model performance was evaluated using C statistics, sensitivity, and specificity.
Results: Of 1 936 957 children, 48.4% were female, 87.8% resided in urban core areas, and 45.1% had government-sponsored insurance as their only primary payer. Depending on the algorithm and coding criteria applied, 0.67% to 11.44% were identified as CMC. All 3 algorithms had adequate discriminative ability, sensitivity, and specificity to predict in-hospital mortality and composite health care services (C statistic = 0.76 [95% CI, 0.73-0.80] to 0.81 [95% CI, 0.78-0.84] for mortality and 0.77 [95% CI, 0.76-0.77] to 0.80 [95% CI, 0.79-0.80] for composite health care services). Across algorithms, CMC had significantly greater odds of mortality (adjusted odds ratio [aOR], 9.97; 95% CI, 7.70-12.89; to aOR, 69.35; 95% CI, 52.52-91.57) and composite health care services (aOR, 4.59; 95% CI, 4.44-4.73; to aOR, 18.87; 95% CI, 17.87-19.93) than children not identified as CMC. Conclusions and Relevance: In this study, open-source algorithms identified different cohorts of CMC in terms of prevalence and magnitude of risk, but all predicted increased health care utilization and in-hospital mortality. These results can inform research, programs, and policies for CMC.

Entities:  

Mesh:

Year:  2022        PMID: 35435932      PMCID: PMC9016603          DOI: 10.1001/jamapediatrics.2022.0687

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   26.796


  1 in total

1.  Febrile children with comorbidities at the emergency department - a multicentre observational study.

Authors:  Dorine M Borensztajn; Nienke N Hagedoorn; Enitan D Carrol; Ulrich von Both; Marieke Emonts; Michiel van der Flier; Ronald de Groot; Jethro Herberg; Benno Kohlmaier; Michael Levin; Emma Lim; Ian K Maconochie; Federico Martinon-Torres; Ruud G Nijman; Marko Pokorn; Irene Rivero-Calle; Maria Tsolia; Fabian J S van der Velden; Clementien Vermont; Dace Zavadska; Werner Zenz; Joany M Zachariasse; Henriette A Moll
Journal:  Eur J Pediatr       Date:  2022-07-07       Impact factor: 3.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.